MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Kymera Therapeutics Historical Prices 2011-2026 | KYMR
Annual Historical Prices Kymera Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93.9 | 30.4 | 40 | 33 | 42 | 62 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 93.9 | 30.4 | 50.2 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Autolus Therapeutics plc
AUTL
|
1.21 | $ 1.35 | -2.91 % | $ 359 M |  Britain |
 |
Coherus BioSciences
CHRS
|
1.93 | $ 1.61 | -3.59 % | $ 189 M |  USA |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | France |
 |
Catalyst Pharmaceuticals
CPRX
|
24.9 | $ 24.88 | -0.4 % | $ 3.04 B | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
9.55 | $ 10.02 | -1.16 % | $ 133 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
Cardiff Oncology
CRDF
|
1.74 | $ 1.57 | -0.63 % | $ 105 M | USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.65 | 1.3 % | $ 8.78 B |  Australia |
 |
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | USA |
 |
DBV Technologies S.A.
DBVT
|
20.2 | $ 20.25 | -0.54 % | $ 2.83 B | France |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
Aytu BioScience
AYTU
|
2.51 | $ 2.55 | -4.14 % | $ 16 M | USA |
 |
Dyadic International
DYAI
|
0.87 | $ 0.87 | - | $ 31.5 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Entera Bio Ltd.
ENTX
|
2.13 | $ 1.17 | -2.1 % | $ 64 M |  Israel |
 |
Equillium
EQ
|
2.06 | $ 2.0 | -0.5 % | $ 115 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
Evogene Ltd.
EVGN
|
1.19 | $ 0.8 | 2.49 % | $ 27.9 M | Israel |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Fate Therapeutics
FATE
|
1.57 | $ 1.15 | -3.78 % | $ 137 M | USA |
 |
Forte Biosciences
FBRX
|
25.9 | $ 26.15 | -1.1 % | $ 339 M | USA |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |
 |
Fennec Pharmaceuticals
FENC
|
5.91 | $ 6.2 | -3.43 % | $ 177 M | USA |
|
Foghorn Therapeutics
FHTX
|
5.65 | $ 4.75 | -2.59 % | $ 299 M | USA |
 |
Amicus Therapeutics
FOLD
|
14.3 | $ 14.46 | 0.03 % | $ 4.46 B | USA |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | Germany |
 |
BioNTech SE
BNTX
|
91.2 | $ 88.37 | -3.19 % | $ 27.2 B | Germany |
 |
Akari Therapeutics, Plc
AKTX
|
0.12 | $ 3.52 | -0.56 % | $ 237 B | Britain |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Fulcrum Therapeutics
FULC
|
8.51 | $ 7.45 | -4.85 % | $ 472 K | USA |
 |
Galectin Therapeutics
GALT
|
2.79 | $ 2.38 | -7.03 % | $ 152 M | USA |
 |
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
311 | $ 315.4 | -4.52 % | $ 41.3 B | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
Gilead Sciences
GILD
|
147 | $ 138.37 | -1.26 % | $ 172 B | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
1.34 | $ 0.54 | 4.26 % | $ 503 K | Israel |
 |
Aileron Therapeutics
ALRN
|
2.13 | - | 10.36 % | $ 9.8 M | USA |
 |
Genmab A/S
GMAB
|
33.5 | $ 27.13 | -2.25 % | $ 17 B |  Danmark |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |